Published in Mol Psychiatry on May 24, 2011
Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine. Nat Neurosci (2015) 2.89
Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet (2011) 2.85
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet (2012) 2.65
Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci (2012) 1.71
Modeling autism by SHANK gene mutations in mice. Neuron (2013) 1.64
SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet (2012) 1.59
Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments. PLoS Genet (2014) 1.57
Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron (2012) 1.52
From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci (2015) 1.44
Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J Biol Chem (2011) 1.40
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet (2012) 1.36
Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J Neurosci (2012) 1.31
Translational approaches to the biology of Autism: false dawn or a new era? Mol Psychiatry (2012) 1.26
Progress toward treatments for synaptic defects in autism. Nat Med (2013) 1.24
Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities. J Neurosci (2013) 1.19
Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms. Neurosci Biobehav Rev (2014) 1.14
Modeling psychiatric disorders at the cellular and network levels. Mol Psychiatry (2012) 1.14
The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines. Transl Psychiatry (2014) 1.09
Nanoscale segregation of actin nucleation and elongation factors determines dendritic spine protrusion. EMBO J (2014) 1.03
High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability. PLoS One (2012) 1.01
Identification and functional characterization of rare SHANK2 variants in schizophrenia. Mol Psychiatry (2015) 1.01
Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol Psychiatry (2011) 0.99
Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators. Cell Rep (2015) 0.96
The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders. Psychopharmacology (Berl) (2013) 0.91
Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism. J Neurosci (2013) 0.91
Autism-Associated Insertion Mutation (InsG) of Shank3 Exon 21 Causes Impaired Synaptic Transmission and Behavioral Deficits. J Neurosci (2015) 0.91
Therapeutic approaches for shankopathies. Dev Neurobiol (2013) 0.90
Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment. J Child Neurol (2015) 0.90
SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region. J Biol Chem (2013) 0.88
Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Front Cell Neurosci (2015) 0.88
Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4-9 Deletion Mouse Model of Autism. Autism Res (2015) 0.87
Rare copy number variation in treatment-resistant major depressive disorder. Biol Psychiatry (2014) 0.86
Translational Concepts of mGluR5 in Synaptic Diseases of the Brain. Front Pharmacol (2012) 0.86
Phenotypic and functional analysis of SHANK3 stop mutations identified in individuals with ASD and/or ID. Mol Autism (2015) 0.86
Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology (Berl) (2014) 0.86
Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders. Hum Genet (2014) 0.85
The adhesion-GPCR BAI3, a gene linked to psychiatric disorders, regulates dendrite morphogenesis in neurons. Mol Psychiatry (2013) 0.85
Shank mutant mice as an animal model of autism. Philos Trans R Soc Lond B Biol Sci (2013) 0.85
Development of social skills in children: neural and behavioral evidence for the elaboration of cognitive models. Front Neurosci (2015) 0.84
Absence of strong strain effects in behavioral analyses of Shank3-deficient mice. Dis Model Mech (2014) 0.82
Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility. Schizophr Bull (2014) 0.81
Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacology (Berl) (2013) 0.80
Shank-cortactin interactions control actin dynamics to maintain flexibility of neuronal spines and synapses. Eur J Neurosci (2015) 0.79
Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders? J Neurosci (2016) 0.79
Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders. Mol Brain (2015) 0.79
Analysis of Proteins That Rapidly Change Upon Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) Repression Identifies Parkinson Protein 7 (PARK7) as a Novel Protein Aberrantly Expressed in Tuberous Sclerosis Complex (TSC). Mol Cell Proteomics (2015) 0.79
Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications. Exp Neurobiol (2015) 0.78
Dileucine and PDZ-binding motifs mediate synaptic adhesion-like molecule 1 (SALM1) trafficking in hippocampal neurons. J Biol Chem (2011) 0.78
Glutamatergic candidate genes in autism spectrum disorder: an overview. J Neural Transm (Vienna) (2014) 0.78
The role of F-actin in modulating Clathrin-mediated endocytosis: Lessons from neurons in health and neuropsychiatric disorder. Commun Integr Biol (2014) 0.78
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism. J Clin Invest (2017) 0.78
Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons. Eur J Neurosci (2015) 0.78
Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum. J Neural Transm (Vienna) (2012) 0.77
Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength. J Neurosci (2016) 0.77
Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis. Hum Mol Genet (2015) 0.77
Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder. Front Physiol (2015) 0.77
Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies. Neural Plast (2016) 0.77
Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol Psychiatry (2016) 0.77
Convergent synaptic and circuit substrates underlying autism genetic risks. Front Biol (Beijing) (2014) 0.77
Autism phenotypes in ZnT3 null mice: Involvement of zinc dyshomeostasis, MMP-9 activation and BDNF upregulation. Sci Rep (2016) 0.76
Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range. J Neural Transm (Vienna) (2014) 0.76
A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons. Front Cell Neurosci (2016) 0.76
Automatic Dendritic Spine Quantification from Confocal Data with Neurolucida 360. Curr Protoc Neurosci (2016) 0.75
SHANK Mutations May Disorder Brain Development. Mol Syndromol (2015) 0.75
Abnormal glutamate release in aged BTBR mouse model of autism. Int J Clin Exp Pathol (2015) 0.75
A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density. J Neurosci (2017) 0.75
Novel functions for ADF/cofilin in excitatory synapses - lessons from gene-targeted mice. Commun Integr Biol (2015) 0.75
Proteomic Analysis of Post-synaptic Density Fractions from Shank3 Mutant Mice Reveals Brain Region Specific Changes Relevant to Autism Spectrum Disorder. Front Mol Neurosci (2017) 0.75
Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders. Neural Plast (2017) 0.75
Defective Gpsm2/Gαi3 signalling disrupts stereocilia development and growth cone actin dynamics in Chudley-McCullough syndrome. Nat Commun (2017) 0.75
Synaptic transmission in neurological disorders dissected by a quantitative approach. Commun Integr Biol (2012) 0.75
Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction. Mol Genet Genomic Med (2016) 0.75
A Novel Human CAMK2A Mutation Disrupts Dendritic Morphology and Synaptic Transmission, and Causes ASD-Related Behaviors. J Neurosci (2017) 0.75
Genome-wide patterns of copy number variation in the Chinese yak genome. BMC Genomics (2016) 0.75
Developmental profiling of ASD-related shank3 transcripts and their differential regulation by valproic acid in zebrafish. Dev Genes Evol (2016) 0.75
SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. Nat Cell Biol (2017) 0.75
A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility. Transl Psychiatry (2017) 0.75
Mice lacking the chromodomain helicase DNA-binding 5 chromatin remodeler display autism-like characteristics. Transl Psychiatry (2017) 0.75
Three-dimensional Quantification of Dendritic Spines from Pyramidal Neurons Derived from Human Induced Pluripotent Stem Cells. J Vis Exp (2015) 0.75
Expression of SHANK3 in the Temporal Neocortex of Patients with Intractable Temporal Epilepsy and Epilepsy Rat Models. Cell Mol Neurobiol (2016) 0.75
An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio. Nat Commun (2017) 0.75
Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders. Mol Psychiatry (2017) 0.75
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet (2006) 8.00
Copy-number variations associated with neuropsychiatric conditions. Nature (2008) 6.78
Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry (2005) 5.52
X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet (2004) 5.15
Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet (2007) 5.04
Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron (1999) 4.59
The epidemiology of autism spectrum disorders. Annu Rev Public Health (2007) 4.52
Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol (2001) 4.38
Molecular mechanisms of dendritic spine morphogenesis. Curr Opin Neurobiol (2005) 4.31
Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron (2001) 3.91
Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci (2008) 3.83
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet (2010) 3.73
Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell (2004) 3.48
A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J Neurosci (2000) 3.28
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
The Shank family of scaffold proteins. J Cell Sci (2000) 3.11
NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat Cell Biol (2003) 3.09
Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet (2001) 3.09
Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci (2005) 2.96
An architectural framework that may lie at the core of the postsynaptic density. Science (2006) 2.91
Rapid turnover of actin in dendritic spines and its regulation by activity. Nat Neurosci (2002) 2.78
The subspine organization of actin fibers regulates the structure and plasticity of dendritic spines. Neuron (2008) 2.76
ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem (2002) 2.71
CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet (2009) 2.41
Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci (2008) 2.27
Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogenesis. Mol Biol Cell (2009) 2.23
Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet (2010) 2.14
Activity-dependent redistribution and essential role of cortactin in dendritic spine morphogenesis. J Neurosci (2003) 2.11
Ontogeny of postsynaptic density proteins at glutamatergic synapses. Mol Cell Neurosci (2005) 2.08
N-wasp and the arp2/3 complex are critical regulators of actin in the development of dendritic spines and synapses. J Biol Chem (2008) 2.05
Role of actin cytoskeleton in dendritic spine morphogenesis. Neurochem Int (2007) 2.00
A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J Neurosci (2007) 1.97
Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet (2008) 1.97
mPins modulates PSD-95 and SAP102 trafficking and influences NMDA receptor surface expression. Nat Cell Biol (2005) 1.78
Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a. J Neurosci (2003) 1.77
Differential control of postsynaptic density scaffolds via actin-dependent and -independent mechanisms. J Neurosci (2006) 1.76
ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory. Mol Cell Biol (2004) 1.70
Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol (1998) 1.68
Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol Cell Neurosci (2001) 1.61
C-terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3. J Neurochem (2005) 1.48
Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family. Biochem Biophys Res Commun (1999) 1.46
Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J (2011) 1.44
Linkage of the actin cytoskeleton to the postsynaptic density via direct interactions of Abp1 with the ProSAP/Shank family. J Neurosci (2004) 1.44
Immunocytochemical localization of actin and microtubule-associated protein MAP2 in dendritic spines. Proc Natl Acad Sci U S A (1983) 1.43
The Shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta PIX guanine nucleotide exchange factor for Rac1 and Cdc42. J Biol Chem (2003) 1.38
Regulation of N-WASP and the Arp2/3 complex by Abp1 controls neuronal morphology. PLoS One (2007) 1.26
The actin-binding protein Abp1 controls dendritic spine morphology and is important for spine head and synapse formation. J Neurosci (2008) 1.24
Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin. J Biol Chem (2001) 1.18
Postsynaptic shank antagonizes dendrite branching induced by the leucine-rich repeat protein Densin-180. J Neurosci (2005) 1.16
Interaction of SPIN90 with the Arp2/3 complex mediates lamellipodia and actin comet tail formation. J Biol Chem (2005) 1.10
Fast regulation of axonal growth cone motility by electrical activity. J Neurosci (2007) 1.00
Calcium-induced inactivation of NMDA receptor-channels evolves independently of run-down in cultured rat brain neurones. J Physiol (1996) 0.91
ProSAP-interacting protein 1 (ProSAPiP1), a novel protein of the postsynaptic density that links the spine-associated Rap-Gap (SPAR) to the scaffolding protein ProSAP2/Shank3. J Biol Chem (2006) 0.91
Modulation of Shank3 PDZ domain ligand-binding affinity by dimerization. Chembiochem (2010) 0.82
Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta (1994) 4.93
Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry (2002) 2.51
Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature (2001) 2.28
PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron (2000) 2.01
Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature (1996) 1.81
Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry (2007) 1.79
Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet (1995) 1.59
Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cytogenet Genome Res (2011) 1.54
Diagnostic approach to mediastinal masses. Eur J Radiol (1998) 1.50
Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation. J Neurosci (2000) 1.43
[High resolution MR imaging of the skin: normal imaging features]. J Radiol (2008) 1.38
Nitric oxide-induced blockade of NMDA receptors. Neuron (1992) 1.35
Ornithine cyclodeaminase from octopine Ti plasmid Ach5: identification, DNA sequence, enzyme properties, and comparison with gene and enzyme from nopaline Ti plasmid C58. J Bacteriol (1989) 1.28
Inborn errors of the Krebs cycle: a group of unusual mitochondrial diseases in human. Biochim Biophys Acta (1997) 1.27
Reference charts for respiratory chain activities in human tissues. Clin Chim Acta (1994) 1.21
The blocking action of baclofen on excitatory transmission in the rat hippocampal slice. J Neurosci (1982) 1.18
Assessment of the mitochondrial respiratory chain. Lancet (1991) 1.16
A simple method to transfer plasmid DNA into neuronal primary cultures: functional expression of the mGlu5 receptor in cerebellar granule cells. Neuropharmacology (1999) 1.16
The Noc region of Ti plasmid C58 codes for arginase and ornithine cyclodeaminase. Eur J Biochem (1987) 1.16
GPCR-interacting proteins (GIPs): nature and functions. Biochem Soc Trans (2004) 1.15
Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature (2014) 1.14
Gene sequence, localization, and evolutionary conservation of DAZLA, a candidate male sterility gene. Genomics (1997) 1.11
Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies. J Pediatr (1994) 1.10
Clinical presentation of mitochondrial disorders in childhood. J Inherit Metab Dis (1996) 1.10
Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry (2012) 1.08
Glutamate receptor targeting in the postsynaptic spine involves mechanisms that are independent of myosin Va. Eur J Neurosci (2001) 1.07
Selective blockade of P/Q-type calcium channels by the metabotropic glutamate receptor type 7 involves a phospholipase C pathway in neurons. J Neurosci (2000) 1.07
Correlation between kinetics and RNA splicing of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in neocortical neurons. Proc Natl Acad Sci U S A (1996) 1.05
Charybdotoxin blocks dendrotoxin-sensitive voltage-activated K+ channels. FEBS Lett (1989) 1.04
The measurement of the rotenone-sensitive NADH cytochrome c reductase activity in mitochondria isolated from minute amount of human skeletal muscle. Biochem Biophys Res Commun (1990) 1.02
Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry (2006) 1.01
Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening. Transl Psychiatry (2013) 1.01
Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans R Soc Trop Med Hyg (2006) 1.00
Evolution of the DAZ gene family suggests that Y-linked DAZ plays little, or a limited, role in spermatogenesis but underlines a recent African origin for human populations. Hum Mol Genet (1998) 0.99
Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder. Mol Psychiatry (2005) 0.97
Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes. J Med Chem (1997) 0.97
Transduction of the human gene FAM8A1 by endogenous retrovirus during primate evolution. Genomics (2001) 0.95
Fluxes of nicotinamide adenine dinucleotides through mitochondrial membranes in human cultured cells. J Biol Chem (1996) 0.95
Classification and properties of acidic amino acid receptors in hippocampus. I. Electrophysiological studies of an apparent desensitization and interactions with drugs which block transmission. J Neurosci (1983) 0.95
[Metastasis on previous hip arthroplasty: three cases]. Rev Chir Orthop Reparatrice Appar Mot (2005) 0.94
PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7. EMBO J (2002) 0.94
Modulation of calcium channels by metabotropic glutamate receptors in cerebellar granule cells. Neuropharmacology (1995) 0.94
[Biliary colonic ileus: an unusual cause of colonic obstruction]. J Radiol (1998) 0.94
mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons. Eur J Neurosci (1999) 0.91
[Percutaneous drainage of infected pancreatic necrosis: an alternative to surgery]. Chirurgie (1999) 0.91
Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. Neuroreport (2004) 0.90
Y chromosome haplogroups in autistic subjects. Mol Psychiatry (2002) 0.90
A high frequency of Y chromosome deletions in males with nonidiopathic infertility. J Clin Endocrinol Metab (1999) 0.89
Cloning and expression of succinic semialdehyde reductase from human brain. Identity with aflatoxin B1 aldehyde reductase. Eur J Biochem (1999) 0.89
The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells. J Neurosci (1994) 0.89
Modulation of big K+ channel activity by ryanodine receptors and L-type Ca2+ channels in neurons. Eur J Neurosci (1998) 0.88
CT and MR of accessory soleus muscle. J Comput Assist Tomogr (1995) 0.88
Early events in the trafficking of N-methyl-D-aspartate (NMDA) receptors. Biochem Soc Trans (2003) 0.87
cAMP-dependent, long-lasting inhibition of a K+ current in mammalian neurons. Proc Natl Acad Sci U S A (1995) 0.87
CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol (1998) 0.87
Regeneration in avian hair cell epithelia: identification of intracellular signals required for S-phase entry. Eur J Neurosci (2001) 0.87
[Spontaneous pneumomediastinum in dermatomyositis: a pathophysiological approach using imaging]. Rev Mal Respir (2003) 0.86
Metabotropic glutamate receptors: an original family of G protein-coupled receptors. Fundam Clin Pharmacol (1993) 0.86
Extreme C terminus of G protein alpha-subunits contains a site that discriminates between Gi-coupled metabotropic glutamate receptors. J Biol Chem (1998) 0.86
An improved spectrophotometric assay of pyruvate dehydrogenase in lactate dehydrogenase contaminated mitochondrial preparations from human skeletal muscle. Clin Chim Acta (1995) 0.85
The action of hydrogen peroxide on paired pulse and long-term potentiation in the hippocampus. Free Radic Biol Med (1989) 0.84
Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures. Neuropharmacology (2000) 0.84
Facilitatory coupling between a glutamate metabotropic receptor and dihydropyridine-sensitive calcium channels in cultured cerebellar granule cells. J Neurosci (1995) 0.84
Identification of the human KIF13A gene homologous to Drosophila kinesin-73 and candidate for schizophrenia. Genomics (2001) 0.84
(trans)-1-amino-cyclopentyl-1,3-dicarboxylate stimulates quisqualate phosphoinositide-coupled receptors but not ionotropic glutamate receptors in striatal neurons and Xenopus oocytes. Mol Pharmacol (1990) 0.84
Expression of GABA(A) receptor subunit mRNAs by layer V pyramidal cells of the rat primary visual cortex. Eur J Neurosci (1997) 0.83
[Use of SSFSE sequence for cine-MRI of the cervical spine in professional front-line rugby players]. J Radiol (2006) 0.83
Stimulation by glutamate receptors of arachidonic acid release depends on the Na+/Ca2+ exchanger in neuronal cells. Mol Pharmacol (1993) 0.83
Phenotypic expression of mitochondrial genotypes in cultured skin fibroblasts and in Epstein-Barr virus-transformed lymphocytes in Pearson syndrome. Muscle Nerve Suppl (1995) 0.83
The influence of helium pressure on the reduction induced in field potentials by various amino acids and on the GABA-mediated inhibition in the CA1 region of hippocampal slices in the rat. Neuropharmacology (1988) 0.82
Voltage-activated calcium channels in rat Purkinje cells maintained in culture. Pflugers Arch (1989) 0.82
[Palliative percutaneous treatment under x-ray computed tomographic control of inoperable pulmonary aspergilloma. Apropos of 30 cases]. Rev Mal Respir (1995) 0.81
CT scan does not improve the reproducibility of trochanteric fracture classification: a prospective observational study of 53 cases. Orthop Traumatol Surg Res (2012) 0.80
Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: case report and review of the literature. Lung Cancer (2013) 0.80
5-HT4 receptors: long-term blockade of K+ channels and effects on olfactory memory. C R Acad Sci III (1998) 0.80
Classification and properties of acidic amino acid receptors in hippocampus. II. Biochemical studies using a sodium efflux assay. Mol Pharmacol (1983) 0.80
A versatile chamber for microphysiologic studies with gas mixtures under high pressure. Undersea Biomed Res (1987) 0.80
[CT-guided percutaneous treatment of inoperable pulmonary aspergilloma. Apropos of 42 cases]. J Radiol (1998) 0.80
The investigation of respiratory chain disorders in heart using endomyocardial biopsies. J Inherit Metab Dis (1993) 0.80
[Superficial US of superficial bones]. J Radiol (2005) 0.80
Inositol-1,4,5-trisphosphate-mediated rescue of cerebellar long-term depression in subtype 1 metabotropic glutamate receptor mutant mouse. Neuroscience (1999) 0.79
A study of spontaneous and evoked activity in the rat hippocampus under helium-oxygen high pressure. Electroencephalogr Clin Neurophysiol (1985) 0.79
[Imaging of traumatic injuries of the shoulder]. J Radiol (2007) 0.79
The C terminus of the metabotropic glutamate receptor subtypes 2 and 7 specifies the receptor signaling pathways. J Biol Chem (2001) 0.79
Uridine preserves the expression of respiratory enzyme deficiencies in cultured fibroblasts. Eur J Pediatr (1993) 0.79
Evoked potential changes in rat hippocampal slices under helium pressure. Exp Brain Res (1987) 0.79
Decrease of recurrent and feed-forward inhibitions under high pressure of helium in rat hippocampal slices. Eur J Pharmacol (1988) 0.79
[Strict anteroposterior radiography of the shoulder: value of the assessment of rotator cuff tears]. J Radiol (2001) 0.78
Excitatory and inhibitory amino-acidergic determinants of the pressure-induced neuronal hyperexcitability in rat hippocampal slices. Undersea Biomed Res (1990) 0.78
Blockade of nitric oxide synthesis by tyrosine kinase inhibitors in neurones. Neuropharmacology (1994) 0.78
Prenatal diagnosis of cytochrome c oxidase deficiency in cultured amniocytes is hazardous. Prenat Diagn (1992) 0.78
[Shoulder radiography: useful radiographic views in current practice]. J Radiol (2008) 0.77
AMPA receptor activation induces association of G-beta protein with the alpha subunit of the sodium channel in neurons. Eur J Neurosci (2001) 0.77
Neurons of the nucleus tractus solitarius, in vitro, generate bursting activities by solitary tract stimulation. Exp Brain Res (1990) 0.77
[Genetic control of spermatogenesis: Y chromosome and male infertility]. Ann Biol Clin (Paris) (1999) 0.77
[Evolution of the pelvis and hip throughout history: from primates to modern man]. J Radiol (2011) 0.77
The metabotropic glutamate receptor (MGR): pharmacology and subcellular location. J Physiol Paris (1992) 0.76
[Thoracic ultrasound]. Rev Pneumol Clin (2000) 0.76
Deep sea diving: human performance and motor control under hyperbaric conditions with inert gas. Adv Neurol (1983) 0.76
Sodium nitroprusside blocks NMDA receptors via formation of ferrocyanide ions. Neuroreport (1992) 0.76